MuRF1/TRIM63, Master Regulator of Muscle Mass

Area of Science:

• Biochemistry
• Molecular Biology
• Physiology

Background:

• MuRF1 (Muscle RING Finger 1) is an E3 ubiquitin ligase implicated in skeletal muscle atrophy.
• Muscle wasting is linked to poor prognosis in diseases like cancer, sepsis, and diabetes.
• MuRF1 exhibits dual roles, detrimental in skeletal muscle but cardioprotective in the heart.

Purpose of the Study:

• To review 20 years of research on MuRF1's structure, regulation, function, and inhibitors.
• To highlight MuRF1's opposing roles in skeletal and cardiac muscle.
• To inform the design of future drugs targeting MuRF1 for muscle wasting conditions.

Main Methods:

• Literature review of studies on MuRF1 in skeletal and cardiac muscle.
• Analysis of data on MuRF1 structure, regulation, localization, and function.
• Examination of reported MuRF1 inhibitors.

Main Results:

• MuRF1 is a key mediator of skeletal muscle atrophy in catabolic states.
• MuRF1 demonstrates cardioprotective functions, contrasting its role in skeletal muscle.
• The review synthesizes current knowledge on MuRF1's complex biology.

Conclusions:

• MuRF1's dual function necessitates careful consideration for therapeutic strategies.
• Targeting MuRF1 offers potential for treating muscle wasting diseases.
• Further research into MuRF1 characteristics is vital for drug development.